Effects of Cisplatin-Loaded Niosomal Nanoparticleson BT-20 Human Breast Carcinoma Cells

Breast cancer is the fifth most common cause of death among women worldwide. Resistance to cisplatin is a main challenge in its treatment. Our present aim was to prepare nanoniosomated cisplatin and examine its efficacy in vitro using the BT-20 cell line. Niosome nanoparticles containing cisplatin w...

Descripción completa

Detalles Bibliográficos
Autores principales: Kanaani, Leila, javadi, Iraj, Ebrahimifar, Meysam, shahmabadi, Hasan Ebrahimi, Khiyavi, Azim Akbarzadeh, Mehrdiba, Torkan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5454728/
https://www.ncbi.nlm.nih.gov/pubmed/28345332
http://dx.doi.org/10.22034/APJCP.2017.18.2.365

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5454728/
https://www.ncbi.nlm.nih.gov/pubmed/28345332
http://dx.doi.org/10.22034/APJCP.2017.18.2.365

Ejemplares similares